Amphastar director granted RSUs and stock options
Amphastar Pharmaceuticals director Richard K. Prins reported new equity awards and prior gifting activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amphastar Pharmaceuticals director Richard K. Prins reported new equity awards and prior gifting activity. On June 1, 2026 he received 8,143 shares of Common Stock in the form of restricted stock units, all vesting on June 1, 2027, and a stock option for 17,365 shares at an exercise price of $18.42 per share that also vests on June 1, 2027 and expires on June 1, 2036. A previously reported bona fide gift on August 19, 2024 transferred 1,500 shares of Common Stock. Following the latest transactions, he beneficially owned 37,598 shares as of June 1, 2026 after an account reconciliation noted in the filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 17,365 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 8,143 | $0.00 | $0.00 |
| Gift | Common Stock | 1,500 | $0.00 | $0.00 |
Footnotes (3)
- F1. The number of shares beneficially owned following the reported transaction is as of June 1, 2026 and has been reduced by 4,228 shares to reflect a reconciliation to the reporting person's account records.
- F2. The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 1, 2027.
- F3. All of the shares subject to the option vest on June 1, 2027.
Key Figures
Key Terms
restricted stock units financial
RSUs financial
Stock Option (right to buy) financial
bona fide gift financial
beneficially owned financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Amphastar (AMPH) director Richard K. Prins report?
How many restricted stock units did the Amphastar (AMPH) director receive and when do they vest?
What are the terms of the new stock option grant reported for Amphastar (AMPH)?
What are Richard K. Prins’s Amphastar (AMPH) holdings after these transactions?
Are the new Amphastar (AMPH) equity awards immediately exercisable or unrestricted?
AI-generated analysis. How Rhea-AI works. Not financial advice.